Although discounted playing cards will help reduce the load of large drug costs in the short-term, they do not deal with the systemic problems driving up prescription prices while in the U.S. Broader policy variations could tackle the root will cause of soaring drug prices, such as insufficient transparency in pricing as well as position of interme